ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS

<p>NEW YORK, Aug. 05, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) resulting from allegations that Apellis may have issued materially misleading business information to the investing public. SO WHAT: If you purchased […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/rosen-global-investor-counsel-encourages-apellis-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-apls/">ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>